Literature DB >> 2929695

Nonstress testing with acoustic stimulation and amniotic fluid volume assessment: 5973 tests without unexpected fetal death.

S L Clark1, P Sabey, K Jolley.   

Abstract

In a 36-month period antepartum testing was performed 5973 times in 2628 women with singleton high-risk pregnancies. The testing scheme involved a modified nonstress test with sound stimulation. Testing was performed twice weekly for patients with diabetes (classes B through R), gestational age exceeding 42 weeks, and documented intrauterine growth retardation, and weekly for other indications. If no spontaneous acceleration was observed within 5 minutes, a single 1- to 2-second sound stimulus was applied to the lower maternal abdomen with an artificial larynx. If necessary, a second sound stimulation was applied within 10 minutes. In addition all patients received ultrasonographic four-quadrant assessment of amniotic fluid volume. The mean testing time was 10 minutes. Only 2% of tests were nonreactive with sound stimulation. Seventeen percent of nonstress tests that were nonreactive with sound stimulation were followed by positive results of a contraction stress test or a biophysical profile score less than or equal to 4. The overall intervention rate was 3%. All fetuses with a single acceleration only eventually met criteria for negative results to a contraction stress test or had a biophysical profile score greater than or equal to 8. There were no unexpected antepartum fetal deaths. Sound-induced accelerations appear to be valid in the prediction of fetal well being, and the use of sound stimulation results in a significant shortening of testing time. Simultaneous assessment of amniotic fluid volume may reduce the risk of fetal death to a negligible level.

Entities:  

Mesh:

Year:  1989        PMID: 2929695     DOI: 10.1016/s0002-9378(89)80062-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Oligoamnios and Perinatal Outcome.

Authors:  Sandhyasri Panda; M Jayalakshmi; G Shashi Kumari; G Mahalakshmi; Y Srujan; V Anusha
Journal:  J Obstet Gynaecol India       Date:  2016-09-06

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

3.  Association of Prenatal Care Services, Maternal Morbidity, and Perinatal Mortality With the Advanced Maternal Age Cutoff of 35 Years.

Authors:  Caroline K Geiger; Mark A Clapp; Jessica L Cohen
Journal:  JAMA Health Forum       Date:  2021-12-03

Review 4.  Biophysical profile for fetal assessment in high risk pregnancies.

Authors:  J G Lalor; B Fawole; Z Alfirevic; D Devane
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 5.  Methods for Monitoring Risk of Hypoxic Damage in Fetal and Neonatal Brains: A Review.

Authors:  Liaisan Uzianbaeva; Yan Yan; Tanaya Joshi; Nina Yin; Chaur-Dong Hsu; Edgar Hernandez-Andrade; Mohammad Mehrmohammadi
Journal:  Fetal Diagn Ther       Date:  2021-12-06       Impact factor: 2.587

6.  Antenatal testing-a reevaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop.

Authors:  Caroline Signore; Roger K Freeman; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.